Depleting anti-CD20 (rhesus recombinant) - afucosylated version QTY 8400 MG

Ended Purchase Order Awarded Last action

Contract number
75N93020P00375
Awardee
Awarding agency
Obligated
$12,600

Award facts

Contract value 100% obligated
$12,600.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Shrewsbury, MA 01545, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 $0
Original award $12,600

Quick answers

Who was awarded contract 75N93020P00375?

75N93020P00375 was awarded to University Of Massachusetts by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on March 10, 2020.

How much is contract 75N93020P00375 worth?

The government has obligated $12,600 on 75N93020P00375.

Which agency awarded contract 75N93020P00375?

National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded 75N93020P00375, with funding from National Cancer Institute (National Institutes of Health).

Was contract 75N93020P00375 competed?

The extent of competition for 75N93020P00375 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login